Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Pogliani

Showing results (31-40 of 54) with videos related to

Pageof 6
Sort By:
British Journal of Haematology|December 1, 1993
Preliminary study to identify cancer patients at high risk of venous thrombosis following major surgeryA Falanga, F A Ofosu, S Cortelazzo, et al.
Seminars in Oncology|December 1, 1993
Intensive therapy for adult acute lymphoblastic leukemia: preliminary results of the idarubicin/vincristine/L-asparaginase/prednisolone regimenR Bassan, R Battista, P Viero, et al.
Leukemia|June 1, 1996
The role of anthracyclines in adult acute lymphoblastic leukaemiaR Bassan, T Lerede, A Rambaldi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 18, 2000
Differential recognition of a BCR/ABL peptide by lymphocytes from normal donors and chronic myeloid leukemia patientsC Bertazzoli, E Marchesi, L Passoni, et al.
Haematologica|May 1, 1990
1,25-Dihydroxyvitamin D3 in the treatment of idiopathic thrombocythemia and myelofibrosisP Foa, A T Maiolo, M Cortellaro, et al.
Leukemia & Lymphoma|September 1, 1993
Idarubicin in the initial treatment of adults with acute lymphoblastic leukemia: the effect of drug schedule on outcomeR Bassan, R Battista, G Corneo, et al.
Thrombosis and Haemostasis|August 13, 1990
Cancer procoagulant in acute non lymphoid leukemia: relationship of enzyme detection to disease activityM B Donati, A Falanga, R Consonni, et al.
Haematologica|November 6, 2001
Response to fludarabine in B-cell chronic lymphocytic leukemia patients previously treated with chlorambucil as up-front therapy and a CHOP-like regimen as second line therapyV Liso, S Molica, S Capalbo, et al.
Leukemia & Lymphoma|July 1, 1996
Age-adapted moderate-dose induction and flexible outpatient postremission therapy for elderly patients with acute lymphoblastic leukemiaR Bassan, E Di Bona, T Lerede, et al.
Leukemia & Lymphoma|June 1, 1997
Granulocyte colony-stimulating factor (G-CSF, filgrastim) after or during an intensive remission induction therapy for adult acute lymphoblastic leukaemia: effects, role of patient pretreatment characteristics, and costsR Bassan, T Lerede, E Di Bona, et al.
Pageof 6

Showing results (31-40 of 54) with videos related to

Sort By:
Pageof 6
British Journal of Haematology|December 1, 1993
Preliminary study to identify cancer patients at high risk of venous thrombosis following major surgeryA Falanga, F A Ofosu, S Cortelazzo, et al.
Seminars in Oncology|December 1, 1993
Intensive therapy for adult acute lymphoblastic leukemia: preliminary results of the idarubicin/vincristine/L-asparaginase/prednisolone regimenR Bassan, R Battista, P Viero, et al.
Leukemia|June 1, 1996
The role of anthracyclines in adult acute lymphoblastic leukaemiaR Bassan, T Lerede, A Rambaldi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 18, 2000
Differential recognition of a BCR/ABL peptide by lymphocytes from normal donors and chronic myeloid leukemia patientsC Bertazzoli, E Marchesi, L Passoni, et al.
Haematologica|May 1, 1990
1,25-Dihydroxyvitamin D3 in the treatment of idiopathic thrombocythemia and myelofibrosisP Foa, A T Maiolo, M Cortellaro, et al.
Leukemia & Lymphoma|September 1, 1993
Idarubicin in the initial treatment of adults with acute lymphoblastic leukemia: the effect of drug schedule on outcomeR Bassan, R Battista, G Corneo, et al.
Thrombosis and Haemostasis|August 13, 1990
Cancer procoagulant in acute non lymphoid leukemia: relationship of enzyme detection to disease activityM B Donati, A Falanga, R Consonni, et al.
Haematologica|November 6, 2001
Response to fludarabine in B-cell chronic lymphocytic leukemia patients previously treated with chlorambucil as up-front therapy and a CHOP-like regimen as second line therapyV Liso, S Molica, S Capalbo, et al.
Leukemia & Lymphoma|July 1, 1996
Age-adapted moderate-dose induction and flexible outpatient postremission therapy for elderly patients with acute lymphoblastic leukemiaR Bassan, E Di Bona, T Lerede, et al.
Leukemia & Lymphoma|June 1, 1997
Granulocyte colony-stimulating factor (G-CSF, filgrastim) after or during an intensive remission induction therapy for adult acute lymphoblastic leukaemia: effects, role of patient pretreatment characteristics, and costsR Bassan, T Lerede, E Di Bona, et al.
Pageof 6